Beryl Drugs Limited is an India-based pharmaceutical manufacturing company which is principally engaged in the manufacturing of bulk drugs. The Company operates in Pharmaceutical Industry segment. In response to product requirements, it provides a variety of manufacturing options, such as small volume injectable in liquid or dry powder form, as well as a selection of eye and ear drops, intravenous (IV) fluids in glass bottles and poly packs, and veterinary medications. It is also involved in domestic, institutional and export supply. The Company uses its nationwide sales and distribution network to market a variety of branded and generic pharmaceutical formulations. Its manufacturing facility is in Pithampur, India.As of 25 May 2026, BERYL DRUGS LTD. share price is ₹19.01. The stock opened at ₹20.80, compared to its previous close of ₹19.81. During today's trading session, BERYL DRUGS LTD. share price moved in the range of ₹19.01 to ₹20.80, with an average price of ₹19.91 for the day. Looking at its last 52-week, the stock has touched a low of ₹19.01 and a high of ₹20.80.
The market capitalization of BERYL DRUGS LTD. is ₹10 Crs, with a P/E ratio of 660.3 and a dividend yield of 0.00%.